Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort

Abstract The evidence regarding the association between infant formula (IF) composition and the prevention of allergy and respiratory diseases remains sparse and inconclusive. This study aimed to evaluate whether some IF characteristics were associated with the risk of allergy or respiratory disease...

Full description

Saved in:
Bibliographic Details
Main Authors: Moufidath Adjibade, Lucille Vigneron, Rosalie Delvert, Karine Adel‐Patient, Amandine Divaret‐Chauveau, Isabella Annesi‐Maesano, Barbara Heude, Marie‐Aline Charles, Blandine deLauzon‐Guillain
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Maternal and Child Nutrition
Subjects:
Online Access:https://doi.org/10.1111/mcn.13673
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849221146933723136
author Moufidath Adjibade
Lucille Vigneron
Rosalie Delvert
Karine Adel‐Patient
Amandine Divaret‐Chauveau
Isabella Annesi‐Maesano
Barbara Heude
Marie‐Aline Charles
Blandine deLauzon‐Guillain
author_facet Moufidath Adjibade
Lucille Vigneron
Rosalie Delvert
Karine Adel‐Patient
Amandine Divaret‐Chauveau
Isabella Annesi‐Maesano
Barbara Heude
Marie‐Aline Charles
Blandine deLauzon‐Guillain
author_sort Moufidath Adjibade
collection DOAJ
description Abstract The evidence regarding the association between infant formula (IF) composition and the prevention of allergy and respiratory diseases remains sparse and inconclusive. This study aimed to evaluate whether some IF characteristics were associated with the risk of allergy or respiratory diseases in childhood. Among 1243 formula‐fed children from the EDEN mother–child cohort, IF characteristics concerning long‐chain polyunsaturated fatty acids (LCPUFAs) enrichment, prebiotic/probiotic enrichment, and hydrolysis of proteins were identified from the ingredients list. Eczema, wheezing, food allergy, asthma, and allergic rhinitis up to age 8 years were prospectively collected and summarized into four allergic and respiratory multimorbidity clusters. Associations between 4‐month IF characteristics and risk of allergy or respiratory diseases were tested using logistic regressions adjusted on main confounders. The consumption of LCPUFA‐enriched formula was not linked to allergic and respiratory multimorbidity clusters, but to a lower risk of any allergy, eczema, and wheezing. Probiotic‐enriched formula consumption was associated with a lower risk of belonging to the ‘Allergy without asthma’ cluster (odds ratio [OR] [95% confidence interval, CI] = 0.63 [0.40–0.99]), and consumption of a formula enriched in Bifidobacterium lactis was associated with a lower risk of any allergy (OR [95% CI] = 0.59 [0.41–0.85]). Partially hydrolysed formula (pHF) consumption was associated with a higher risk of belonging to the ‘Allergy without asthma’ cluster (OR [95% CI] = 2.73 [1.65–4.51]). This study confirms the positive association between pHF consumption and the risk of allergy found in previous observational studies and suggests that consumption of LCPUFA‐enriched or probiotic‐enriched formula was associated with a lower risk of allergy.
format Article
id doaj-art-bfad5b52c39f4221b9c76bc18a6247d6
institution Kabale University
issn 1740-8695
1740-8709
language English
publishDate 2024-10-01
publisher Wiley
record_format Article
series Maternal and Child Nutrition
spelling doaj-art-bfad5b52c39f4221b9c76bc18a6247d62024-11-19T11:34:12ZengWileyMaternal and Child Nutrition1740-86951740-87092024-10-01204n/an/a10.1111/mcn.13673Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohortMoufidath Adjibade0Lucille Vigneron1Rosalie Delvert2Karine Adel‐Patient3Amandine Divaret‐Chauveau4Isabella Annesi‐Maesano5Barbara Heude6Marie‐Aline Charles7Blandine deLauzon‐Guillain8Université Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, CRESS Paris FranceUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, CRESS Paris FranceUniversité Paris‐Saclay, UVSQ, Univ. Paris‐Sud, Inserm, Équipe d'Épidémiologie respiratoire intégrative, CESP Villejuif FranceUniversité Paris‐Saclay, CEA, INRAE, DMTS Gif‐sur‐Yvette FranceUR 3450, Laboratoire DevAH, Université de Lorraine Vandoeuvre‐lès‐Nancy FranceDesbrest Institute of Epidemiology and Public Health (IDESP), Montpellier University and INSERM Montpellier FranceUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, CRESS Paris FranceUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, CRESS Paris FranceUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, CRESS Paris FranceAbstract The evidence regarding the association between infant formula (IF) composition and the prevention of allergy and respiratory diseases remains sparse and inconclusive. This study aimed to evaluate whether some IF characteristics were associated with the risk of allergy or respiratory diseases in childhood. Among 1243 formula‐fed children from the EDEN mother–child cohort, IF characteristics concerning long‐chain polyunsaturated fatty acids (LCPUFAs) enrichment, prebiotic/probiotic enrichment, and hydrolysis of proteins were identified from the ingredients list. Eczema, wheezing, food allergy, asthma, and allergic rhinitis up to age 8 years were prospectively collected and summarized into four allergic and respiratory multimorbidity clusters. Associations between 4‐month IF characteristics and risk of allergy or respiratory diseases were tested using logistic regressions adjusted on main confounders. The consumption of LCPUFA‐enriched formula was not linked to allergic and respiratory multimorbidity clusters, but to a lower risk of any allergy, eczema, and wheezing. Probiotic‐enriched formula consumption was associated with a lower risk of belonging to the ‘Allergy without asthma’ cluster (odds ratio [OR] [95% confidence interval, CI] = 0.63 [0.40–0.99]), and consumption of a formula enriched in Bifidobacterium lactis was associated with a lower risk of any allergy (OR [95% CI] = 0.59 [0.41–0.85]). Partially hydrolysed formula (pHF) consumption was associated with a higher risk of belonging to the ‘Allergy without asthma’ cluster (OR [95% CI] = 2.73 [1.65–4.51]). This study confirms the positive association between pHF consumption and the risk of allergy found in previous observational studies and suggests that consumption of LCPUFA‐enriched or probiotic‐enriched formula was associated with a lower risk of allergy.https://doi.org/10.1111/mcn.13673allergyinfant formulalong‐chain polyunsaturated fatty acidspartially hydrolysed formulaprobiotics
spellingShingle Moufidath Adjibade
Lucille Vigneron
Rosalie Delvert
Karine Adel‐Patient
Amandine Divaret‐Chauveau
Isabella Annesi‐Maesano
Barbara Heude
Marie‐Aline Charles
Blandine deLauzon‐Guillain
Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
Maternal and Child Nutrition
allergy
infant formula
long‐chain polyunsaturated fatty acids
partially hydrolysed formula
probiotics
title Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
title_full Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
title_fullStr Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
title_full_unstemmed Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
title_short Characteristics of infant formula consumed in the first months of life and allergy in the EDEN mother–child cohort
title_sort characteristics of infant formula consumed in the first months of life and allergy in the eden mother child cohort
topic allergy
infant formula
long‐chain polyunsaturated fatty acids
partially hydrolysed formula
probiotics
url https://doi.org/10.1111/mcn.13673
work_keys_str_mv AT moufidathadjibade characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT lucillevigneron characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT rosaliedelvert characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT karineadelpatient characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT amandinedivaretchauveau characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT isabellaannesimaesano characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT barbaraheude characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT mariealinecharles characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort
AT blandinedelauzonguillain characteristicsofinfantformulaconsumedinthefirstmonthsoflifeandallergyintheedenmotherchildcohort